drugset / Trial / NCT01951898

Effects of Montelukast on Airway Regulatory T Cells in Asthma

NCT01951898

Phase 2/3 Unknown 15 enrolled Kurume University
RandomizedCrossoverDouble-blindTreatment

Summary

Montelukast is one of anti-inflammatory agents and a good controller for the patients with asthma. The hypothesis of the study is that the Montelukast will have airway anti-inflammatory effects and up-regulated regulatory T cells functions in asthma.

Timeline

Start
2012-06
Primary completion
2013-12
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg

Indications